コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 receptor in the single MPhi response to beta-hemolytic streptococci.
2 only a disk approximation test for the beta-hemolytic streptococci.
3 oth test for inducible CC resistance in beta-hemolytic streptococci.
4 ultures grew morphologically identical alpha-hemolytic streptococci.
5 cultures yielded predominant growth of alpha-hemolytic streptococci.
6 atment of pharyngitis caused by group A beta-hemolytic streptococci.
7 s, and Fusobacterium species as well as beta-hemolytic streptococci.
10 een infectious agents and autoimmunity: beta-hemolytic streptococci and rheumatic fever; B3 Coxsackie
15 r cellulitis without purulent drainage, beta-hemolytic streptococci are presumed to be the predominan
16 ophorum (polymerase chain reaction) and beta-hemolytic streptococci (culture) in the Skane Region, Sw
17 ble clindamycin resistance can occur in beta-hemolytic streptococci due to the presence of an erm gen
18 s a reliable method for grouping of the beta-hemolytic streptococci encountered in clinical laborator
19 sceptibility data for staphylococci and beta-hemolytic streptococci from 52 U.S. medical centers that
20 ents with cultures positive for group A beta-hemolytic streptococci (GABHS) and 61% of patients with
24 The Lyra assay correctly detected all beta-hemolytic streptococci (group A, n = 19; group C/G, n =
25 ife-threatening conditions often caused by B-hemolytic streptococci, group A Streptococcus (GAS) in p
28 ts that are widely used for grouping of beta-hemolytic streptococci in clinical laboratories use liqu
30 resence of clindamycin resistance among beta-hemolytic streptococci infections (1.86; 1.10-3.16).
31 e presence of clindamycin resistance among B-hemolytic streptococci infections (1.86; 1.10-3.16).
34 between these outcomes and the presence of B-hemolytic streptococci or clindamycin-resistant B-hemoly
35 ween these outcomes and the presence of beta-hemolytic streptococci or clindamycin-resistant beta-hem
36 ater risk of limb loss among patients with B-hemolytic streptococci-particularly clindamycin-resistan
37 r risk of limb loss among patients with beta-hemolytic streptococci-particularly clindamycin-resistan
39 aureus, Staphylococcus lugdunensis, non-beta-hemolytic streptococci, Streptococcus-like bacteria, Str
40 atment of pharyngitis caused by group A beta-hemolytic streptococci that could be given once daily an
41 ell-known tendency of cellulitis due to beta-hemolytic streptococci to recur, little is known regardi
42 occus aureus, Streptococcus pneumoniae, beta-hemolytic streptococci, vancomycin-resistant Enterococcu
45 c streptococci or clindamycin-resistant beta-hemolytic streptococci were calculated using log-binomia
46 ytic streptococci or clindamycin-resistant B-hemolytic streptococci were calculated using log-binomia